Boston Trust Walden Corp Purchases 10,913 Shares of The Clorox Company (NYSE:CLX)

Boston Trust Walden Corp lifted its position in shares of The Clorox Company (NYSE:CLX) by 4.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 284,821 shares of the company’s stock after purchasing an additional 10,913 shares during the period. Boston Trust Walden Corp owned 0.23% of Clorox worth $46,258,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Brooklyn Investment Group lifted its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new position in Clorox during the third quarter worth about $27,000. Continuum Advisory LLC raised its stake in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Quarry LP boosted its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC acquired a new position in shares of Clorox during the 3rd quarter worth approximately $48,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

CLX stock opened at $159.80 on Tuesday. The stock has a market cap of $19.78 billion, a price-to-earnings ratio of 55.68, a P/E/G ratio of 2.92 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a 50 day simple moving average of $162.76 and a 200 day simple moving average of $158.50. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the prior year, the firm earned $2.16 earnings per share. Research analysts anticipate that The Clorox Company will post 6.86 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.05%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Barclays dropped their price target on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Finally, Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $156.07.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.